Logistic regression generated probability estimates for trisomy 21 outcomes from serum alpha fetoprotein and beta human chorionic gonadotrophin: Simplification with increased specificity

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 5, Issue 1, 1996, Pages 1-6

  Evans, Mark I ^a,b,e   Chick, Lawrence ^a   O'Brien, Joseph E ^d   Dvorin, Elena ^c   Johnson, Mark P ^a,b   Krivchenia, Eric ^a   Sokol, Robert J ^a  

^a HUTZEL HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MetPath Laboratories   (United States)

^d Hutzel Hospital ^*  (United States)

^e WAYNE STATE UNIVERSITY   (United States)

Author keywords

Logistic regression analysis; Maternal serum alpha fetoprotein; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; FETUS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROBABILITY; REGRESSION ANALYSIS; RISK ASSESSMENT; TRISOMY 21;

ALPHA-FETOPROTEINS; ANEUPLOIDY; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DNA; DOWN SYNDROME; FEMALE; GENETIC SCREENING; HUMANS; LINEAR MODELS; PREGNANCY; PREGNANCY OUTCOME; PROBABILITY; REGRESSION ANALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0029939412     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.3109/14767059609025386     Document Type: Article

References (13)

1. Wald NJ, Cuckle HS, Densem JW, Nanchalal KJ, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA: Maternal serum screening for Down syndrome in early pregnancy. Br Med J 297:883-887, 1988.
2. Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE: A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, HCG, and unconjugated estriol. Obstet Gynecol 81:72-77, 1993.
3. Wald N, Densem J, Stone R, Cheng R: The use of free β-hCg in antenatal screening for Down's syndrome. Br J Obstet Gynaecol 100: 550-557, 1993.
4. Goodburn SF, Yates JRW, Raggatt PR, Carr C, Ferguson-Smith ME, Kershaw AJ, Milton PJD, Ferguson-Smith MA: Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programme. Prenat Diagn 14:391-402, 1994.
5. Crossley JA, Aitken DA, Connor JM: Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age. Prenat Diagn 11:83-101, 1991.
6. Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA: Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 330(16): 1114-1118, 1994.
7. Wald NJ, Smith D, Kennard A, Palomaki GE, Salonen R, Holzgreve W, Pejtsik B, Coombes EJ, Mancini G, MacRae AR, Wyatt P, Roberson J: Biparietal diameter and crown-rump length in fetuses with Down's syndrome: Implications for antenatal serum screening for Down's syndrome. Br J Obstet Gynaecol 100:430-435, 1993.
8. Spencer K: Antenatal screening for Down's syndrome. Br Med J 306:1616, 1993.
9. Evans MI, Chik L, O'Brien JE, Chen B, Dvorin E, Ayoub M, Krivchenia EL, Ager JW, Johnson MP, Sokol RJ: MOMs and DADs: Improved specificity and cost effectiveness of biochemical screening for aneuploidy with DADs. Am J Obstet Gynecol 172:1138-1147, 1995.
10. Petrocik E, Wassman ER, Kelly JC: Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels. Am J Obstet Gynecol 161:1168-1173, 1989.
11. Kelly JC, Lee J, Petrocik E, Wassman ER: Prenatal Down syndrome screening using a combinational analysis of maternal age, serum alpha-fetoprotein and serum human chorionic gonadotropin. Am J Human Genet 45: 262, 1989.
12. Del Junco D, Granberg F, Darnule A, Contant C, Weyland B, Schmidt D, Faucett A, Rose E, Alpert E: Statistical analysis of maternal age, maternal serum alpha fetoprotein, beta human chorionic gonadotropin, and unconjugated estriol for Down syndrome screening in midtrimester. Am J Human Genet 45:a257, 1989.
13. Petrocik E, Wassman ER, Lee JJ, Kelly JC: Second trimester maternal serum pregnancy specific beta-1 glycoprotein (SP-1) levels in normal and Down syndrome pregnancies. Am J Med Genet 37:114-118, 1990.